dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2020-12-10T20:11:11Z | |
dc.date.accessioned | 2022-12-19T20:26:48Z | |
dc.date.available | 2020-12-10T20:11:11Z | |
dc.date.available | 2022-12-19T20:26:48Z | |
dc.date.created | 2020-12-10T20:11:11Z | |
dc.date.issued | 2019-10-05 | |
dc.identifier | Toxicon. Oxford: Pergamon-elsevier Science Ltd, v. 168, p. S5-S6, 2019. | |
dc.identifier | 0041-0101 | |
dc.identifier | http://hdl.handle.net/11449/197260 | |
dc.identifier | 10.1016/j.toxicon.2019.06.042 | |
dc.identifier | WOS:000565210200019 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5377898 | |
dc.language | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation | Toxicon | |
dc.source | Web of Science | |
dc.title | PROSPECTING, DEVELOPMENT, OPTIMIZATION AND CLINICAL TRIAL OF NEW ANTIAPILIC ANTIVENOM | |
dc.type | Otros | |